Vizgen

Innovative Spatial Biology Technology

Cambridge, United States · Founded 2019 · $158.2M raised

Employees
51–200
Founded
2019
Business Model
B2B
Website
vizgen.com
Total Funding
$158.2M
Last Round
$85.2M Series CJun 2022
Rounds
4

About

Vizgen is redefining how scientists see and understand biology as a leader in spatial multiomics, delivering single-cell, spatially resolved data with AI-powered analysis for researchers, clinicians, and biopharma teams. Founded in 2019 to improve human health through spatial genomics, the company built on MERFISH technology exclusively licensed from Harvard University and launched the MERSCOPE platform to map RNA and protein molecules with subcellular precision. In 2024, Vizgen merged with Ultivue to combine single-cell spatial genomics with multiplex proteomic biomarker detection. More than 200 MERSCOPE platforms are installed globally, and Vizgen operates facilities in Cambridge and Waltham, Massachusetts.

Summary

Vizgen is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $158.2M in total across 4 rounds, most recently a $85.2M Series C round in Jun 2022. Investors include Northpond Ventures, Kenneth Chien / Novalis LifeSciences and ARCH Venture Partners.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJun 2022
$85.2M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vizgen on Indexed.vc
<a href="https://indexed.vc/companies/vizgen"><img src="https://indexed.vc/api/badge/company/vizgen" alt="Vizgen on Indexed.vc" width="260" height="76" /></a>